All News

Two case studies presented by researchers from the Cleveland Clinic raise new questions about the link between weight and diabetes.

After the passage of the 2008 Mental Health Parity and Addiction Equity Act, children with autism spectrum disorder used more mental health services and functional therapies while out-of-pocket spending remained level, according to a recent study.

Payment reform in the United States has been going on for years, and a panel at the AcademyHealth National Health Policy Conference analyzed how much progress has been made to move away from fee-for-service, and what the evidence on alternative payment models has found.

CMS has touted an upgraded reporting system to spot overpayments, but only 18 states have implemented it so far.

The Health Care Working Group of the Personalized Medicine Coalition (PMC) has published a new report that provides a framework for the successful integration of personalized medicine in the clinic.

The trials now recruiting involve larger groups of patients for longer periods of time, as well as less restrictive settings.

Women with breast cancer are twice as likely to return to work after treatment if their employer makes accommodations for them, but workplace accommodation and job retention are significantly lower for low-income and minority women.

A treatment for juvenile Batten disease has been tested in a mouse model and the results have shown reduced in symptoms and improved longevity. The results of the study were published in Nature Communications.

A recent study indicated that strategies to promote weight loss or maintenance across an entire population could be more effective in preventing type 2 diabetes than programs specifically targeting obese people at high risk of developing the disease.

Lung cancer screening rates in the United States remained low and unchanged in 2015 despite recommendations that high-risk current and former smokers be screened.

Buy in from physicians and lack of enthusiasm from payers are seen as barriers to moving quickly into value-based models.

Feedback received by the Institute of Clinical Effectiveness Research during this time will be evaluated and incorporated as seen fit, before the final changes are made to the framework.

Early discharge from the emergency department resulted in more than 10,000 Medicare patients dying, annually. Researchers determined that low-volume hospitals actually had higher rates of early death.

Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.

A recent literature review confirmed that adult offspring of people with chronic obstructive pulmonary disease are at higher risk of being diagnosed with the disease themselves.

A recent study in BMJ Open Diabetes Research & Care indicates that the prevalence of diabetes is higher among individuals infected with HIV than in the general population.

The National Health Policy Conference hosted by AcademyHealth, January 30-31, 2017, in Washington DC, delivered on its promise of insightful discussions on the current and future trends within healthcare.

This week, the top managed care stories included Republicans pushing HHS secretary nominee Tom Price, R-Georgia, through without Democrats, PhRMA meeting with President Donald Trump, and patients complaining of price fixing in an insulin lawsuit.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Reports explain that plans for Medicaid block grants or per capita caps overlook who really uses Medicaid. It's mostly children.

Significant reductions in A1C were found at both doses, and bigger declines were seen among patients with the worst glycemic control. The cardiovascular outcomes trial for the SGLT2 inhibitor took a different turn after a rival drug showed a CV benefit.

The University of Michigan Center for Value-Based Insurance Design (V-BID) celebrated significant initiative milestones in 2016.

A review of 15 disease-modifying therapies (DMTs) for the treatment of relapsing-remitting and primary-progressive multiple sclerosis (MS) has found that prices for most of these drugs are not well-aligned with added value for patients.

A white paper commissioned by the Community Oncology Alliance (COA) delved into the practice of “direct and indirect remuneration” fees administered by pharmacy benefit managers and how they could drive up drug prices for Medicare Part D beneficiaries and taxpayers.

A study last year found that more than half of all California adults have diabetes or prediabetes.